Bengaluru-based cell therapy company Eyestem has raised $6.4 million in its Series A round led by three pharma giants – Biological E, Alkem, Natco and Anurag and Kemwell Biopharma promoter Karan Bagaria.

Existing investors Endiya Partners and Kotak Private Equity also participated in the round, which valued Eyestem at $46.4 million. Eyestem founder and CEO Dr Jogin Desai spoke to CNBC-TV18 about the fundraising campaign and the road ahead.

Meanwhile, a public spat between Changpeng Zhao, CEO of global cryptocurrency platform Binance, and Nischal Shetty, co-founder of WazirX, has affected 15 million registered users of the Indian cryptocurrency exchange. Shetty maintains that Binance owns WazirX and has access to crypto assets, profits and servers. He also stated that he has legal documents proving that Binance owns WazirX.

Binance, on the other hand, insists that it has no control over operations such as “user registration, KYC, transactions, and initiating withdrawals.”

Additionally, wealth creation platform Dezerv raised $21 million in a Series A round led by Accel, with participation from existing investors Matrix Partners India and Elevation Capital. The new funding round comes after the startup showed significant growth and invested over Rs 800 crore through the platform.